Blade Therapeutics is advancing novel anti-fibrotic therapies to meet important patient needs in an area that has seen little innovation to date. Several rare/orphan and chronic debilitating conditions manifest as a consequence of fibrosis, a complex, pathologic process in which progressive scarring replaces functional tissue. Blade Therapeutics is seeking to develop therapies to modify disease progression, and in some cases, potentially reverse the fibrotic damage to tissue.
